Osteocalcin and Chinese visceral adiposity index are associated with the risk of ASCVD and arterial stiffness in patients with T2DM
Scientific Reports · 2024
DOI: 10.1038/s41598-024-77620-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Caixia Gong und 9 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China. Hauptthemen laut MEDLINE: Osteocalcin, Vascular Stiffness, Diabetes Mellitus, Type 2, Atherosclerosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Hospital Fund of the First Hospital of Lanzhou University, National Natural Science Foundation of China, Health industry scientific research project of Gansu Province.
Abstract (Originalsprache)
This study aims to discover the association between serum osteocalcin, the Chinese visceral adiposity index (CVAI), and atherosclerotic cardiovascular disease (ASCVD) risk, and their impact on arterial stiffness in T2DM patients. We included 639 T2DM patients aged 30 and older who received the assessment of ASCVD risk using the China-PAR equation, Osteocalcin and arterial stiffness in this cross-sectional study. We found that osteocalcin and CVAI as independent risk factors for both medium-high-risk ASCVD (osteocalcin: men, OR,0.96, 95% CI 0.92, 1.00; women, OR, 0.93, 95% CI 0.8, 1.08, respectively)(CVAI: men, OR,1.01,95% CI 1.00,1.02; women: OR, 1.08, 95% CI 1.02,1.14, respectively) and arterial stiffness (osteocalcin: men, OR, 0.98, 95% CI 0.94,1.01; women, OR, 0.98, 95% CI 0.90,1.06, respectively)(CVAI: men, OR,1.0, 95% CI 0.99,1.01; women, OR, 1.02, 95% CI 1.00,1.04, respectively) in both men and women patients with T2DM. Combining osteocalcin levels and CVAI improved the prediction accuracy of arterial stiffness in men patients with T2DM (difference of AUC(Model 4 vs. Model 1):1.5%, NRI: 0.06 [0.0,0.4]). All P-values were < 0.05. The results suggested that osteocalcin levels and CVAI are independent risk factors for ASCVD risk and arterial stiffness in T2DM. Combining osteocalcin and CVAI can enhance the early detection of atherosclerosis through male patients with T2DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
- Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
- Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China. ljf824168@126.com.
Förderung
- The Hospital Fund of the First Hospital of Lanzhou University
- National Natural Science Foundation of China
- Health industry scientific research project of Gansu Province
Zitieren
APA
Gong, C., Chen, C., Zhao, Y., Wang, Y., Li, K., Lv, X., Gao, J., Zhao, P., Fu, S., & Liu, J. (2024). Osteocalcin and Chinese visceral adiposity index are associated with the risk of ASCVD and arterial stiffness in patients with T2DM. Scientific Reports. https://doi.org/10.1038/s41598-024-77620-2
Vancouver
Gong C, Chen C, Zhao Y, Wang Y, Li K, Lv X, et al. Osteocalcin and Chinese visceral adiposity index are associated with the risk of ASCVD and arterial stiffness in patients with T2DM. Scientific Reports. 2024. doi:10.1038/s41598-024-77620-2
BibTeX
@article{Gong2024,
author = {Gong, Caixia and Chen, Chongyang and Zhao, Yangting and Wang, Yawen and Li, Kai and Lv, Xiaoyu and Gao, Jie and Zhao, Pingping and Fu, Songbo and Liu, Jingfang},
title = {Osteocalcin and Chinese visceral adiposity index are associated with the risk of ASCVD and arterial stiffness in patients with T2DM},
journal = {Scientific Reports},
year = {2024},
doi = {10.1038/s41598-024-77620-2}
}
EUVIMED